ITMI20021860A1 - USE OF TRIPTANS AS ANTI-VIRAL AGENTS. - Google Patents

USE OF TRIPTANS AS ANTI-VIRAL AGENTS.

Info

Publication number
ITMI20021860A1
ITMI20021860A1 IT001860A ITMI20021860A ITMI20021860A1 IT MI20021860 A1 ITMI20021860 A1 IT MI20021860A1 IT 001860 A IT001860 A IT 001860A IT MI20021860 A ITMI20021860 A IT MI20021860A IT MI20021860 A1 ITMI20021860 A1 IT MI20021860A1
Authority
IT
Italy
Prior art keywords
triptans
viral agents
viral
agents
Prior art date
Application number
IT001860A
Other languages
Italian (it)
Inventor
Scalia Antonio Cassar
Original Assignee
Scalia Antonio Cassar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scalia Antonio Cassar filed Critical Scalia Antonio Cassar
Priority to IT001860A priority Critical patent/ITMI20021860A1/en
Priority to AU2003273803A priority patent/AU2003273803A1/en
Priority to PCT/EP2003/009435 priority patent/WO2004019934A1/en
Publication of ITMI20021860A1 publication Critical patent/ITMI20021860A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT001860A 2002-08-28 2002-08-28 USE OF TRIPTANS AS ANTI-VIRAL AGENTS. ITMI20021860A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT001860A ITMI20021860A1 (en) 2002-08-28 2002-08-28 USE OF TRIPTANS AS ANTI-VIRAL AGENTS.
AU2003273803A AU2003273803A1 (en) 2002-08-28 2003-08-26 Use of triptans as antiviral agents
PCT/EP2003/009435 WO2004019934A1 (en) 2002-08-28 2003-08-26 Use of triptans as antiviral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001860A ITMI20021860A1 (en) 2002-08-28 2002-08-28 USE OF TRIPTANS AS ANTI-VIRAL AGENTS.

Publications (1)

Publication Number Publication Date
ITMI20021860A1 true ITMI20021860A1 (en) 2004-02-29

Family

ID=31972200

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001860A ITMI20021860A1 (en) 2002-08-28 2002-08-28 USE OF TRIPTANS AS ANTI-VIRAL AGENTS.

Country Status (3)

Country Link
AU (1) AU2003273803A1 (en)
IT (1) ITMI20021860A1 (en)
WO (1) WO2004019934A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102219725B (en) * 2010-04-16 2013-10-09 中国科学院上海药物研究所 Benzohetercyclic compound as well as preparation method and applications thereof
AR088463A1 (en) 2011-10-21 2014-06-11 Abbvie Inc METHODS FOR HCV TREATMENT
ES2527544T1 (en) 2011-10-21 2015-01-26 Abbvie Inc. Mono treatment (PSI-7977) or combination with ADF for use in the treatment of HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
WO2017189978A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
US11400136B2 (en) * 2017-06-19 2022-08-02 President And Fellows Of Harvard College Methods and compositions for treating a microbial infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001107A1 (en) * 1994-07-06 1996-01-18 Bo Arne Hofmann Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses

Also Published As

Publication number Publication date
AU2003273803A1 (en) 2004-03-19
WO2004019934A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
NL1025068A1 (en) Pyrrolopyrimidine derivatives.
DE60324099D1 (en) DRUG-CONTAINING TAMPON
ATE460418T1 (en) HETEROCYCLOCARBOXAMIDE DERIVATIVES
ATE450506T1 (en) INDOLE-3-SULFUR DERIVATIVES
ATE467631T1 (en) QUINUCLIDINAMIDE DERIVATIVES
ATE438644T1 (en) CHINAZOLINE DERIVATIVES
DK2248807T3 (en) N-phenyl-2-pyrimidineamine derivatives
IS7653A (en) MCHIR antidote
DE60234477D1 (en) ACCUMULATORS-liquid spray
DE60307512D1 (en) 3H-CHINAZOLINE -4-ON DERIVATIVES
DE60229592D1 (en) Wheel bearings
BR0300119B1 (en) aqueous composition.
DE60326190D1 (en) of the body
DE50305140D1 (en) atomization
ITMI20021860A1 (en) USE OF TRIPTANS AS ANTI-VIRAL AGENTS.
DE50308133D1 (en) ULTRASOUND-wave atomizer
DE50313548D1 (en) atomization
FI20020530A0 (en) Interferometer
FR2838029B1 (en) RING
ITMI20030916A1 (en) HAND.
DE60226903D1 (en) delay interferometer
ATA18182002A (en) WHEEL
BR0304867B1 (en) arrangement of two joints.
FR2839258B1 (en) Walker SEE
DE60301264D1 (en) AMORPHE CITALOPRAM SALT